Madam Narasa, Mosleh Wassim, Punnanithinont Natdanai, Carmona-Rubio Andres, Said Zaid H, Sharma Umesh C
University at Buffalo, The State University of New York, Division of Cardiology, Clinical and Translation Research Center, Buffalo, NY, USA.
Clin Med Insights Circ Respir Pulm Med. 2018 Feb 11;12:1179548418758021. doi: 10.1177/1179548418758021. eCollection 2018.
Pulmonary hypertension (PH) is an underdiagnosed cause for chest pain in patients without significant coronary artery disease (CAD). Studies showed that enlarged pulmonary arterial (PA) and right ventricular chamber sizes correlate with the severity of PH. Therefore, we studied the association between chest pain, right ventricular dimensions (RVDs), and PA size on coronary coronary tomographic angiography (CCTA).
The CCTA of 87 patients presenting with chest pain without evidence of obstructive CAD was examined. The PA diameter (PAD), right atrial dimension (RAD), and RVD were measured. A comparative control cohort included 31 patients who presented without cardiopulmonary complaints and underwent thoracic CT. The risk for obstructive sleep apnea (OSA) was assessed using STOP-BANG questionnaires.
Patients with chest pain without obstructive CAD showed markedly dilated right atrial and ventricular chambers compared with standard parameters (right atrium: 48 ± 6.4 mm; right ventricle long axis: 61 ± 9.5 mm). When comparing chest pain vs non-chest pain group, respectively, the mean PAD measured 25.92 ± 0.43 mm vs 22.89 ± 0.38 mm ( < .001), RAD2 measured 40.1423 ± 0.7108 mm vs 34.8800 ± 1.0245 mm ( = .0048), and RVD2 measured 31.7729 ± 0.7299 mm vs 27.6379 ± 1.6178 mm ( = .034). Chest pain was associated with higher PAD (odds ratio [OR]: 11.11, < .05) after adjusting for age, sex, body mass index, history of hypertension, hyperlipidemia, congestive heart failure, chronic obstructive pulmonary disease, OSA, and smoking. The chest pain group had a mean STOP-BANG score of 3.9 ± 1.8 in all patients, and 3.62 ± 0.20 in patients without known history of OSA, representing an elevated risk index for the disease.
In patients presenting with chest pain without obstructive CAD on CCTA, there is a strong association between the presence of chest pain and enlarged PAD. They also represent a high-risk group for OSA.
肺动脉高压(PH)是无明显冠状动脉疾病(CAD)患者胸痛的一个未被充分诊断的原因。研究表明,肺动脉(PA)和右心室腔大小的增大与PH的严重程度相关。因此,我们研究了胸痛、右心室尺寸(RVD)和冠状动脉CT血管造影(CCTA)上PA大小之间的关联。
对87例有胸痛且无阻塞性CAD证据的患者进行CCTA检查。测量PA直径(PAD)、右心房尺寸(RAD)和RVD。一个对照队列包括31例无心肺症状并接受胸部CT检查的患者。使用STOP-BANG问卷评估阻塞性睡眠呼吸暂停(OSA)的风险。
与标准参数相比,无阻塞性CAD的胸痛患者显示右心房和心室腔明显扩张(右心房:48±6.4mm;右心室长轴:61±9.5mm)。分别比较胸痛组和非胸痛组时,平均PAD为25.92±0.43mm对22.89±0.38mm(P<.001),RAD2为40.1423±0.7108mm对34.8800±1.0245mm(P = .0048),RVD2为31.7729±0.7299mm对27.6379±1.6178mm(P = .034)。在调整年龄、性别、体重指数、高血压病史、高脂血症、充血性心力衰竭、慢性阻塞性肺疾病、OSA和吸烟因素后,胸痛与较高的PAD相关(比值比[OR]:11.11,P<.05)。胸痛组所有患者的平均STOP-BANG评分为3.9±1.8,无OSA已知病史的患者为3.62±0.20,表明该疾病的风险指数升高。
在CCTA上有胸痛且无阻塞性CAD的患者中,胸痛的存在与PAD增大之间存在密切关联。他们也是OSA的高危人群。